Use of tocilizumab in kidney transplant recipients with COVID-19.
Pérez-Sáez MJ, Blasco M, Redondo-Pachón D, Ventura-Aguiar P, Bada-Bosch T, Pérez-Flores I, Melilli E, Sánchez-Cámara LA, López-Oliva MO, Canal C, Shabaka A, Garra-Moncau N, Martín-Moreno PL, López V, Hernández-Gallego R, Siverio O, Galeano C, Espí-Reig J, Cabezas CJ, Rodrigo MT, Llinàs-Mallol L, Fernández-Reyes MJ, Cruzado-Vega L, Pérez-Tamajón L, Santana-Estupiñán R, Ruiz-Fuentes MC, Tabernero G, Zárraga S, Ruiz JC, Gutiérrez-Dalmau A, Mazuecos A, Sánchez-Álvarez E, Crespo M, Pascual J; Spanish Society of Nephrology COVID-19 Group.
Pérez-Sáez MJ, et al. Among authors: galeano c.
Am J Transplant. 2020 Nov;20(11):3182-3190. doi: 10.1111/ajt.16192. Epub 2020 Aug 4.
Am J Transplant. 2020.
PMID: 32654422
Free PMC article.